{ "@context": "https://schema.org", "@type": "MedicalWebPage", "@id": "https://www.laaap.org/hematuria-and-proteinuria-in-children#webpage", "url": "https://www.laaap.org/hematuria-and-proteinuria-in-children", "name": "Hematuria and Proteinuria in Children: A Pediatric Approach", "headline": "Hematuria and Proteinuria in Children: A Pediatric Approach", "description": "A pediatric clinician's guide to hematuria and proteinuria in children: differential diagnosis, urinalysis workup, glomerular causes, biopsy indications, and when to refer to nephrology. From the LA AAP.", "inLanguage": "en-US", "isPartOf": { "@type": "WebSite", "@id": "https://www.laaap.org/#website", "name": "Louisiana Chapter of the American Academy of Pediatrics", "url": "https://www.laaap.org/" }, "publisher": { "@type": "Organization", "@id": "https://www.laaap.org/#organization", "name": "Louisiana Chapter of the American Academy of Pediatrics", "alternateName": "LA AAP", "url": "https://www.laaap.org/" }, "lastReviewed": "2026-06-10", "audience": { "@type": "MedicalAudience", "audienceType": "Clinician" }, "about": [ { "@type": "MedicalSignOrSymptom", "name": "Hematuria" }, { "@type": "MedicalSignOrSymptom", "name": "Proteinuria" } ], "mentions": [ { "@type": "MedicalCondition", "name": "IgA nephropathy" }, { "@type": "MedicalCondition", "name": "Post-infectious glomerulonephritis" }, { "@type": "MedicalCondition", "name": "Thin basement membrane disease" }, { "@type": "MedicalCondition", "name": "Alport syndrome" }, { "@type": "MedicalCondition", "name": "Nephrotic syndrome" }, { "@type": "MedicalCondition", "name": "Nephrolithiasis" }, { "@type": "MedicalCondition", "name": "Nephrocalcinosis" } ], "image": [ "https://cdn.prod.website-files.com/68924d8deb73df5efb0a19ce/6a2a037200adfa28ce8f4d39_rbc-casts-glomerular-hematuria.avif", "https://cdn.prod.website-files.com/68924d8deb73df5efb0a19ce/6a2a0372a2ed2cfc47f67a59_iga-nephropathy-histology.avif", "https://cdn.prod.website-files.com/68924d8deb73df5efb0a19ce/6a2a03729840c0614fc40d6b_renal-ultrasound-kidney-stone.avif", "https://cdn.prod.website-files.com/68924d8deb73df5efb0a19ce/6a2a0371a9f54cc57bc18bcc_renal-ultrasound-nephrocalcinosis.avif" ], "author": { "@type": "Person", "name": "Caroline Straatmann, MD", "jobTitle": "Pediatric Nephrologist", "affiliation": { "@type": "MedicalOrganization", "name": "LSU Health Pediatric Nephrology" } }, "citation": [ { "@type": "ScholarlyArticle", "name": "Approach to the Child with Hematuria", "author": "Brown DM, Reidy KJ", "isPartOf": { "@type": "Periodical", "name": "Pediatric Clinics of North America" }, "datePublished": "2019" }, { "@type": "ScholarlyArticle", "name": "Hematuria and Proteinuria in Children", "author": "Viteri B, Reid-Adam J", "isPartOf": { "@type": "Periodical", "name": "Pediatrics in Review" }, "datePublished": "2018" }, { "@type": "ScholarlyArticle", "name": "Hematuria", "author": "Massengill SF", "isPartOf": { "@type": "Periodical", "name": "Pediatrics in Review" }, "datePublished": "2008" } ] }

Hematuria and Proteinuria in Children: A Pediatric Approach

Hematuria and proteinuria are among the most common findings on pediatric urinalysis — and among the most clinically anxiety-provoking. Most cases are transient and benign, but persistent findings on repeat testing can signal underlying renal disease. This clinical reference, prepared by Caroline Straatmann, MD of LSU Pediatric Nephrology for the LA AAP's Red Stick Potpourri CME conference, walks Louisiana pediatricians through the differential diagnosis, initial evaluation, and criteria for nephrology referral when blood or protein appears in a child's urine.

Join us for Pediatrics from the Parishes, August 13-16, 2026 at the Roosevelt Hotel in New Orleans, Louisiana.Pediatrics from the Parishes Conference logo

Pediatrics from the Parishes

A Conference Reimagined

August 13 - 16, 2026
The Roosevelt Hotel • New Orleans, LA

Clinical Reference · Pediatric Nephrology

Hematuria and Proteinuria in Children

A practical primary-care approach to evaluating blood and protein in the urine — defining what is benign versus concerning, which tests to order, and when to refer to pediatric nephrology.

Microscopic & Gross Hematuria Benign vs. Abnormal Proteinuria When to Refer

1 Overview

Hematuria and proteinuria are the hallmarks of many renal diseases — yet red blood cells or protein are frequently found in the urine of otherwise healthy children and adolescents. Distinguishing benign findings from true kidney disease is the central task.

Because most isolated findings are transient and benign, the AAP removed routine urine screening from well-child visit recommendations in 2008. When an abnormality is detected, the most important first step is simply to repeat the test before pursuing an extensive workup.

~5%School-age children with MHU
1–2%With persistent MHU
1.3/1000Visits with gross hematuria
>90%Proteinuria that is benign

2 Microscopic Hematuria

Microscopic hematuria (MHU) is usually an incidental finding of unknown duration. A urine dipstick detects heme pigment, but the presence of red blood cells must be confirmed on microscopy, since the dipstick also reacts to myoglobin and hemoglobin.

  • Definition — >3–5 RBCs/HPF in centrifuged urine on at least 2–3 occasions
  • Transient causes — fever, exercise, UTI, trauma, perineal irritation
  • Persistent MHU — >5 RBCs/HPF for more than 4–6 weeks, evaluated independent of trauma, exercise, menstrual cycle, or sexual activity
  • Demographics — girls more than boys; not age-dependent; most often transient and resolves spontaneously
First step for asymptomatic MHU on a screening UA: repeat the urinalysis with microscopy every 1–2 weeks ×2 to confirm RBCs are truly present before any further evaluation.

Initial evaluation of isolated MHU

  • UA with microscopy
  • Urine calcium/creatinine ratio
  • Urine protein/creatinine ratio
  • Imaging is not routinely indicated (consider renal ultrasound in infants)
  • Urology evaluation is not indicated; follow-up is important
Red blood cell casts on urine microscopy, indicating glomerular hematuria
Red blood cell casts on urine microscopy — a finding that points to a glomerular source of hematuria.

Hypercalciuria

Hypercalciuria is a common, often isolated cause of hematuria, and may be associated with nephrocalcinosis or stones. Age-specific spot urine calcium/creatinine thresholds:

Spot urine calcium/creatinine thresholds by age
AgeUrine Ca/Cr (mg/mg)
>2 years>0.2
6–12 months>0.6
<6 months>0.8

Confirm with a 24-hour urine: >4 mg/kg/day is abnormal.

Renal ultrasound demonstrating nephrocalcinosis
Renal ultrasound — nephrocalcinosis.
Renal ultrasound demonstrating a kidney stone with acoustic shadowing
Renal ultrasound — kidney stone.

3 Differential Diagnosis of Microscopic Hematuria

Persistent, asymptomatic, isolated MHU has both nonglomerular and glomerular causes. A family history is important — particularly for hereditary nephritis and thin basement membrane disease.

  • Idiopathic — the most common outcome; no cause identified
  • Hypercalciuria
  • Thin basement membrane disease (TBMD) — benign familial hematuria
  • IgA nephropathy
  • Alport syndrome
  • Acute or chronic glomerular disease — IgA nephropathy, post-infectious GN, HSP (IgA vasculitis)

4 Gross Hematuria

Gross hematuria is alarming to families but frequently has a benign or self-limited cause. Urine color and timing offer diagnostic clues.

Color and timing clues in gross hematuria
FeatureSuggests
Red urine, clotsLower urinary tract
Brown / tea-colored urineUpper urinary tract (glomerular)
Bleeding at voiding onsetUrethral bleeding
Terminal hematuriaBladder or urethral bleeding
Red/pink/brown urine, negative dipstickFoods (beets, blackberries, paprika), drugs (sulfonamides, nitrofurantoin, salicylates, phenazopyridine), urate crystals
Heme-positive, no RBCs on microMyoglobinuria (rhabdomyolysis) or hemoglobinuria (hemolysis)

Causes of gross hematuria

  • Most common — UTI (not if asymptomatic), trauma, perineal irritation
  • Less common — sickle cell disease/trait, TBMD/Alport, hypercalciuria, nephrolithiasis, glomerulonephritis (PIGN, IgA nephropathy), urologic structural abnormalities (UPJO, cysts, ureterocele, bladder polyp), coagulopathies, drug-induced cystitis, Wilms tumor
No diagnosis is found in up to 35% of gross hematuria cases. Reported yield of evaluation: acute GN ~25%, hypercalciuria ~15%, IgA nephropathy ~15%, other ~5%, unknown (possible TBMD) ~40%.

Evaluation of gross hematuria

  • Assess severity — BMP, urine protein/creatinine ratio
  • Diagnostic workup — C3 and anti-streptococcal titers, urine Ca/Cr, urine culture, renal ultrasound
  • Doppler — for renal arterial or venous thrombosis (RVT presents as gross hematuria in a nephrotic newborn or child)
  • Further as indicated — ANA, C3/C4, ANCA, sickle cell screen, hearing evaluation if positive family history, VCUG/cystoscopy if lower-tract symptoms

5 Glomerular Causes of Hematuria

Causes of glomerular hematuria — isolated renal vs. multisystem
Isolated renal diseaseMultisystem disease
Post-infectious GN (post-streptococcal)HSP nephritis
IgA nephropathy (Berger disease)SLE nephritis
Alport syndrome (hereditary)HUS
Thin glomerular basement membrane diseaseGranulomatosis with polyangiitis
Membranoproliferative GNPolyarteritis nodosa
Membranous nephropathyGoodpasture syndrome
Focal segmental glomerulosclerosisHIV nephropathy
Anti-glomerular basement membrane diseaseSickle cell glomerulopathy

Post-infectious glomerulonephritis (PIGN)

  • Classic presentation: red-brown or cola-colored urine (~70%) with nephritic syndrome — hypertension and edema from salt and water retention
  • Microscopic hematuria present in ~100%
  • Antecedent GAS throat infection (1–2 weeks prior) or skin infection (2–6 weeks prior)
  • Laboratory hallmark: low C3, normal C4

IgA nephropathy

IgA nephropathy classically presents with recurrent gross hematuria (40–55%) triggered by an upper respiratory or GI infection, occurring within days of the infection — distinct from the 1–2 week lag of PIGN. Persistent microscopic hematuria between episodes is seen in 30–40%.

Renal biopsy histology of IgA nephropathy with mesangial proliferation and immunofluorescence showing IgA deposition
IgA nephropathy on renal biopsy — light microscopy (left) and immunofluorescence demonstrating mesangial IgA deposition (right).

Thin basement membrane disease (TBMD)

  • Also called benign familial hematuria or hereditary nephritis without deafness
  • Autosomal dominant; persistent MHU or episodic gross hematuria
  • Generally a benign course without CKD progression — but a subset develop progressive proteinuria and renal failure

Alport syndrome

  • Gross and microscopic hematuria; ~80% X-linked (also AR and AD)
  • Abnormal type-4 collagen in the glomerular basement membrane
  • Associated eye and ear abnormalities; ESRD particularly in males; female carriers may have hematuria

6 Indications for Renal Biopsy

  • Evidence of nephritis and APSGN ruled out — hypertension, edema, proteinuria, or renal insufficiency
  • Positive ANA with low C3
  • Gross hematuria lasting more than 2 weeks
  • Frequent recurrent episodes
Microscopic hematuria with proteinuria is renal disease until proven otherwise and warrants a renal biopsy. Persistent proteinuria is the more concerning of the two findings.

7 Proteinuria & Quantification

The dipstick detects albumin and is graded by concentration — which makes it sensitive to how dilute or concentrated the urine is. False positives occur with high specific gravity and alkaline (high-pH) urine.

Urine dipstick protein grades
DipstickProteinInterpretation
Neg / trace<30 mg/dLMay be abnormal in dilute urine
1+30–100 mg/dLMay be normal in concentrated urine
2+100–300 mg/dLAbnormal
3+300–1000 mg/dLAbnormal
Any dipstick ≥1+: obtain a first-morning urinalysis and a urine protein/creatinine (UPC) ratio for confirmation and quantification.

Quantification thresholds

Quantifying proteinuria
MethodNormalAbnormal / nephrotic
Spot urine protein/creatinine (mg/mg)
Children >2 years<0.2>2–3 = nephrotic range
Children 6–24 months<0.5>2–3 = nephrotic range
Timed (24-hour) collection
Adolescents & adultsUp to 200 mg/day>1000 mg/m²/day = nephrotic
Children<4 mg/m²/hr>40 mg/m²/hr = nephrotic

Obtain a urine creatinine to confirm adequacy of a timed collection. Because the protein/creatinine ratio normalizes for urine concentration, it gives the same value (e.g., 0.2) whether the patient is in antidiuresis or diuresis — which is exactly why it is more reliable than the dipstick.

8 Benign vs. Persistent Proteinuria

Most proteinuria detected on screening is benign — transient or orthostatic. Persistent proteinuria is the pattern that warrants concern.

  • False positive — high specific gravity, alkaline urine
  • Transient — fever, acute illness, exercise, stress, dehydration, cold exposure
  • Orthostatic — increased excretion when upright, normal when recumbent
  • Persistent — glomerular (glomerular disease) or tubular (tubulointerstitial disease/injury); benign in >90%, but silent renal disease in ~10%
Prevalence of Proteinuria by Age & Sex 0 2 4 6 8 10 Prevalence (%) 6 8 10 12 14 16 18 Age (years) ♀ Female ♂ Male
Prevalence of proteinuria peaks in adolescence — earlier in females (~13 years) than males (~16 years). Reconstructed from Straatmann, LA AAP Red Stick Potpourri 2022.

Benign orthostatic proteinuria

  • Increased protein excretion when upright, normal when recumbent
  • On average <1 g/24h upright; most common during adolescence
  • Benign — no increase in renal morbidity over 50-year follow-up
☀ Daytime (upright/active) ☾ Overnight (recumbent) Urine protein 8 AM 8 PM 8 AM Glomerulonephritis (~2 g/24h) Benign proteinuria (<1 g/24h)
Diurnal pattern: benign (orthostatic) proteinuria spikes with daytime upright activity and falls to near zero overnight, whereas glomerular disease produces sustained proteinuria day and night. Reconstructed schematic.

Persistent proteinuria — further evaluation

  • Laboratory — CBC, CMP, C3/C4 (SLE, MPGN, APSGN), ANA, hepatitis B/C, HIV
  • Consider renal biopsy — minimal change disease, FSGS, membranous nephropathy, MPGN, C3 glomerulopathy, congenital nephrotic syndrome, diabetes, SLE, CKD from nephron loss

A spot microalbumin/creatinine ratio is a highly sensitive test for small amounts of urinary albumin, useful in obesity, diabetes, sickle cell disease, and Alport syndrome.

9 Nephrotic Syndrome

Nephrotic syndrome is defined by the tetrad of:

  • Nephrotic-range proteinuria
  • Hypoalbuminemia (serum albumin <2.5 g/dL)
  • Edema
  • Hyperlipidemia

10 When to Refer & Who Needs an Annual UA

Indications for nephrology referral

  • Gross hematuria without a clear cause (UTI, PIGN)
  • Symptomatic microscopic hematuria
  • Asymptomatic microscopic hematuria — annual follow-up to monitor for proteinuria and revisit family history
  • Persistent asymptomatic hematuria with ≥1+ proteinuria
  • Coexistent hypertension, edema, or acute kidney injury
Before referring: repeat urine samples, and repeat blood pressures manually and over time. Many abnormalities resolve on repeat testing.

Children who warrant an annual screening UA

  • History of prematurity (<32 weeks), very low birth weight, significant NICU course, or umbilical arterial catheter
  • Congenital heart disease
  • Recurrent UTI, hematuria, or proteinuria
  • Known renal disease or urologic malformation
  • Solid-organ transplant, bone marrow transplant, or malignancy
  • Prolonged treatment with nephrotoxic drugs, or recurrent episodes of AKI
  • Family history of inherited renal disease

11 Practice Pearls

  • Repeat all abnormal urine testing ×2 before an extensive workup.
  • Hematuria with proteinuria is renal disease until proven otherwise and requires a renal biopsy.
  • Proteinuria is more concerning for underlying kidney disease than isolated microscopic hematuria.
  • Most adolescents with proteinuria on a screening UA do not have renal disease — it resolves on repeat testing.
  • The urine protein/creatinine ratio is a high-value test; ideally collect a first-morning sample.
  • Isolated, intermittent (orthostatic) proteinuria is not a sign of renal disease.
  • Let the history and physical exam guide the evaluation, and teach families how to collect a proper first-morning urine.
Source & attribution. Adapted for clinician reference from Caroline Straatmann, MD (LSU Pediatric Nephrology), "Hematuria and Proteinuria," presented at the Louisiana Chapter–AAP Red Stick Potpourri, 2022. Key references include Brown D, Reidy K. Approach to the Child with Hematuria. Pediatr Clin North Am. 2019;66:15–30; Viteri B, Reid-Adam J. Hematuria and Proteinuria in Children. Pediatr Rev. 2018;39:573–587; and Massengill S. Hematuria. Pediatr Rev. 2008;29:342–347.

This page is an educational summary for healthcare professionals and does not replace individual clinical judgment or the cited primary sources. Diagnostic thresholds and management should be applied in the context of the full clinical picture.